Cargando…
Resveratrol prevents p53 aggregation in vitro and in breast cancer cells
One potential target for cancer therapeutics is the tumor suppressor p53, which is mutated in more than 50% of malignant tumors. Loss of function (LoF), dominant negative (DN) and gain of function (GoF) mutations in p53 are associated with amyloid aggregation. We tested the potential of resveratrol,...
Autores principales: | Ferraz da Costa, Danielly C., Campos, Nathali P.C., Santos, Ronimara A., Guedes-da-Silva, Francisca Hildemagna, Martins-Dinis, Mafalda Maria D.C., Zanphorlin, Letícia, Ramos, Carlos, Rangel, Luciana P., Silva, Jerson L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044377/ https://www.ncbi.nlm.nih.gov/pubmed/30018739 http://dx.doi.org/10.18632/oncotarget.25631 |
Ejemplares similares
-
Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020) -
Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and Therapy
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020) -
Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2017) -
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
por: de Oliveira, Guilherme A. P., et al.
Publicado: (2015) -
The aggregation of mutant p53 produces prion-like properties in cancer
por: Rangel, Luciana P, et al.
Publicado: (2014)